Browse by author
Lookup NU author(s): Dr Chris Kotanidis
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2018, © 2018 Taylor & Francis. Purpose/Aim of the Study: Osteoprotegerin (OPG) is an α tumor necrosis factor receptor superfamily glucoprotein that acts as a decoy receptor for the receptor activator of nuclear factor kappa B ligand (RANKL), exerting an antiresoptive bone effect. It was recently shown that OPG/RANKL axis is activated during vascular calcification, contributing to atherosclerotic lesions formation. Additionally, OPG levels are characterized as an independent risk factor for overall vascular mortality in obese adults. We aimed to investigate OPG levels in children/adolescents with obesity and explore possible relations with obesity-related insulin resistance (IR). Material and Methods: A total of 160 participants (85 obese) were enrolled. Participants with obesity underwent an oral glucose tolerance test. IR was evaluated according to the homeostasis model assessment-insulin resistance index. Serum OPG levels were determined. Results: OPG levels did not differ significantly between obese subjects and controls in the total sample (p = 0.133). However, in the adolescents’ subgroup, serum OPG levels were significantly increased in obesity (p = 0.019). After stratifying participants according to their IR status, only subjects with both obesity and IR exhibited increased OPG levels compared to controls (p < 0.001). Factor analysis further associated OPG levels variation to insulin levels variation and to IR. Conclusions: Obese individuals demonstrate increased serum OPG levels during puberty. Obesity per se is not the potent factor for this increase; indeed, IR accompanying obesity seems to exert a fundamental role in OPG upregulation.
Author(s): Kotanidou EP, Kotanidis CP, Giza S, Serbis A, Tsinopoulou V-R, Karalazou P, Tzimagiorgis G, Galli-Tsinopoulou A
Publication type: Article
Publication status: Published
Journal: Endocrine Research
Year: 2019
Volume: 44
Issue: 1-2
Pages: 9-15
Online publication date: 07/06/2018
Acceptance date: 16/05/2018
ISSN (print): 0743-5800
ISSN (electronic): 1532-4206
Publisher: Taylor and Francis Ltd
URL: https://doi.org/10.1080/07435800.2018.1480630
DOI: 10.1080/07435800.2018.1480630
PubMed id: 29877745
Altmetrics provided by Altmetric
